Overview

Yael Schneidman is the Co-Founder and CEO of AccUrine Ltd., a biomedical company developing rapid urine-based diagnostic tests for infection and inflammation. She holds an MBA in Business Administration from Reichman University, a Bachelor’s degree in Law (LLB) from the Academic Center of Law, and a Bachelor’s degree in Economics and Business Management from Bar-Ilan University. 

Before founding AccUrine, Yael co-founded and led Salus Ltd., a healthcare management startup providing holistic, high-quality medical services, which was sold in a multi-million exit deal to Novolog Group.

She also founded YA Investments, through which investments are made in innovative companies. Yael brings strong entrepreneurial and business leadership skills, combining strategic thinking with hands-on management experience and a proven ability to translate innovation into sustainable business growth.